Dicyclomine hydrochloride 2 MG/ML Oral Solution — RxCUI 991082
RxNorm drug concept · Semantic clinical drug
RxCUI 991082
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI991082
Official nameDicyclomine hydrochloride 2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdicyclomine HCl 10 MG per 5 ML Oral Solution; dicyclomine HCl 10 MG in 5 mL Oral Solution
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)31,499 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dicyclomine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats functional bowel/irritable bowel syndrome. It helps calm the spasms and cramping in your intestines.
- The capsules, tablets and solution are taken by mouth, generally four times a day. Your prescriber may adjust the amount after a week or so. If you miss a dose, just carry on with...
- Dry mouth, dizziness and blurred vision are the most common. Nausea, drowsiness, weakness and nervousness can happen too. Be careful driving until you know how it affects you.
- Call if you feel confused, see or hear things that aren't there, have a racing heartbeat, or can't pass urine. Also call if you overheat without sweating or have diarrhea with a co...
🕸️ Concept Web — How Dicyclomine hydrochloride 2 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dicyclomine hydrochloride 2 MG/ML Oral Solution
RxCUI 991082 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Dicyclomine
3361IN -
Dicyclomine hydrochloride
152021PIN
-
Dicyclomine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dicyclomine Oral Solution
371815SCDF -
Dicyclomine hydrochloride Oral Solution
2646528SCDFP -
Dicyclomine Oral Liquid Product
1151167SCDG -
Dicyclomine Oral Product
1151168SCDG -
Dicyclomine hydrochloride Oral Liquid Product
2662657SCDGP -
Dicyclomine hydrochloride Oral Product
2659854SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Dicyclomine Oral Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dicyclomine hydrochloride 2 MG/ML
991081SCDC
-
Dicyclomine hydrochloride 2 MG/ML
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dicyclomine hydrochloride 2 MG/ML
SCDC · 991081 -
Dicyclomine Oral Solution
SCDF · 371815 -
Dicyclomine hydrochloride Oral Solution
SCDFP · 2646528 -
Dicyclomine Oral Liquid Product
SCDG · 1151167 -
Dicyclomine Oral Product
SCDG · 1151168 -
Dicyclomine hydrochloride Oral Liquid Product
SCDGP · 2662657 -
Dicyclomine hydrochloride Oral Product
SCDGP · 2659854
📦 FDA Products & Package NDCs
4 products · 5 package NDCs
5 package NDCs map to RxCUI 991082 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00054-0622-63 | 473 mL in 1 BOTTLE (0054-0622-63) | Dicyclomine Hydrochloride | Hikma Pharmaceuticals USA Inc. | 2020-05-22 |
| 00603-1161-58 | 473 mL in 1 BOTTLE, PLASTIC (0603-1161-58) | dicyclomine hydrochloride | Par Health USA, LLC | 2005-06-23 |
| 17856-2261-01 | 72 mL in 1 BOX, UNIT-DOSE (17856-2261-1) | Dicyclomine Hydrochloride | ATLANTIC BIOLOGICALS CORP. | 2025-03-04 |
| 17856-2261-02 | 72 mL in 1 BOX, UNIT-DOSE (17856-2261-2) | Dicyclomine Hydrochloride | ATLANTIC BIOLOGICALS CORP. | 2025-03-04 |
| 70954-0261-10 | 473 mL in 1 BOTTLE (70954-261-10) | Dicyclomine Hydrochloride | Novitium Pharma LLC | 2021-04-23 |
Observed labelers:
ATLANTIC BIOLOGICALS CORP. (2) ·
Hikma Pharmaceuticals USA Inc. (1) ·
Novitium Pharma LLC (1) ·
Par Health USA, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.1859
Range $0.1859–$0.1859
· middle 50% $0.1859–$0.1859
· 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.